Results 1 to 10 of about 3,631,955 (312)

Secondary Immunodeficiency [PDF]

Allergy, Asthma & Clinical Immunology
The field of medicine is constantly changing and, as healthcare providers, we are fortunate to be practicing in a time when patients are living longer and novel therapeutic options continue to evolve.
Persia Pourshahnazari, Stephen D. Betschel, Vy. H. D. Kim, Susan Waserman, Rongbo Zhu, Harold Kim   +5 more
doaj   +4 more sources

Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis [PDF]

Tuberculosis and Respiratory Diseases
Bronchiectasis is a chronic respiratory disease characterized by abnormal dilation of the bronchi that causes cough, sputum, and recurrent infections. As it may be associated with various respiratory or systemic diseases, a critical aspect of managing ...
Sungmin Zo, Ji-Yong Moon, Kyung Hoon Min, Hyun Lee   +3 more
doaj   +3 more sources

Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency [PDF]

Frontiers in Microbiology, 2022
Since the end of 2019, the world has been challenged by the coronavirus disease 2019 (COVID-19) pandemic. With COVID-19 cases rising globally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, resulting in the emergence of
Nathan M. Markarian, Nathan M. Markarian, Nathan M. Markarian, Gaël Galli, Gaël Galli, Gaël Galli, Gaël Galli, Dhanesh Patel, Dhanesh Patel, Mark Hemmings, Priya Nagpal, Albert M. Berghuis, Levon Abrahamyan, Silvia M. Vidal, Silvia M. Vidal   +14 more
doaj   +3 more sources

Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience [PDF]

Frontiers in Immunology, 2022
BackgroundIndividuals with primary and secondary immunodeficiency (PID/SID) were shown to be at risk of poor outcomes during the early stages of the SARS-CoV-2 pandemic.
Adrian M. Shields, Adrian M. Shields, Susan Tadros, Adam Al-Hakim, Jeremy M. Nell, Me Me Nay Lin, Michele Chan, Sarah Goddard, John Dempster, Magdalena Dziadzio, Smita Y. Patel, Smita Y. Patel, Shuayb Elkalifa, Aarnoud Huissoon, Christopher J. A. Duncan, Archana Herwadkar, Sujoy Khan, Claire Bethune, Suzanne Elcombe, James Thaventhiran, Paul Klenerman, David M. Lowe, David M. Lowe, Sinisa Savic, Siobhan O. Burns, Siobhan O. Burns, Alex G. Richter, Alex G. Richter   +27 more
doaj   +3 more sources

Development of a predictive machine learning model for pathogen profiles in patients with secondary immunodeficiency [PDF]

BMC Medical Informatics and Decision Making
Background Secondary immunodeficiency can arise from various clinical conditions that include HIV infection, chronic diseases, malignancy and long-term use of immunosuppressives, which makes the suffering patients susceptible to all types of pathogenic ...
Qianning Liu, Yifan Chen, Peng Xie, Ying Luo, Buxuan Wang, Yuanxi Meng, Jiaqian Zhong, Jiaqi Mei, Wei Zou   +8 more
doaj   +3 more sources

Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review [PDF]

Frontiers in Oncology, 2023
IntroductionPatients with hematological malignancies (HMs), like chronic lymphocytic leukemia (CLL), multiple myeloma (MM), and non-Hodgkin lymphoma (NHL), have a high risk of secondary immunodeficiency (SID), SID-related infections, and mortality. Here,
Stephen Jolles, Sergio Giralt, Tessa Kerre, Hillard M. Lazarus, S. Shahzad Mustafa, S. Shahzad Mustafa, Roberto Ria, Donald C. Vinh   +7 more
doaj   +3 more sources

Patient-reported outcomes with subcutaneous immunoglobulin in secondary immunodeficiency [PDF]

Frontiers in Immunology
Subcutaneous (SCIG) and intravenous immunoglobulin (IVIG) replacement are both used to prevent infections in patients with secondary immunodeficiency (SID).
Juthaporn Cowan, Juthaporn Cowan, Juthaporn Cowan, Il-Kang Na, Il-Kang Na, Il-Kang Na, Il-Kang Na, André Gladiator, Marta Kamieniak, S. Shahzad Mustafa, S. Shahzad Mustafa   +10 more
doaj   +3 more sources

Immunization of children with secondary immunodeficiency. [PDF]

Hum Vaccin Immunother, 2015
The main causes of secondary immunodeficiency at a pediatric age include infectious diseases (mainly HIV infection), malignancies, haematopoietic stem cell or solid organ transplantation and autoimmune diseases. Children with secondary immunodeficiency have an increased risk of severe infectious diseases that could be prevented by adequate vaccination ...
Esposito S, Prada E, Lelii M, Castellazzi L.   +3 more
europepmc   +6 more sources

Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis. [PDF]

Cancers (Basel), 2023
Simple Summary The prospective, observation Facilitated Immunoglobulin Administration Registry And Outcomes (FIGARO) study was conducted to assess the clinical use and tolerability of facilitated subcutaneous immunoglobulin (fSCIG). In this report, final
Dimou M, Speletas M, Milito C, Pyzik A, Huscher D, Kamieniak M, Pittrow D, Borte M.   +7 more
europepmc   +2 more sources

Goldenhar syndrome: a cause of secondary immunodeficiency? [PDF]

Allergy, Asthma & Clinical Immunology, 2012
Goldenhar syndrome (GS) results from an aberrant development of the 1st and 2nd branchial arches. There is a wide range of clinical manifestations, the most common being microtia, hemifacial microsomia, epibulbar dermoids and vertebral malformations.
De Golovine Serge, Wu Shuya, Hunter Jill V, Shearer William T   +3 more
doaj   +3 more sources